Complement-induced protection: an explanation for the limitations of cell-based tumour immunotherapies
Immunology & Cell Biology, 07/11/2012
Kempshall E et al. – Complement could thus be limiting the efficacy of natural killer (NK) and T cell–targeted cancer therapies, and the inclusion of complement inhibitors could optimise these immunotherapeutic regimes.



